Loblaw reports Q2 profit of $751M, as revenue and sales up from a year ago
Loblaw Cos. Ltd. reported its second-quarter profit and revenue rose compared with a year ago.
The company behind Loblaws and Shoppers Drug Mart says it had a profit attributable to common shareholders of $751 million or 64 cents per diluted share for the 12-week period ended June 20, up from $714 million or 59 cents per diluted share a year earlier.
Revenue, including both its retail operations and the PC Financial business which is being sold to EQB Inc., totalled $15.27 billion, up from $14.67 billion in the second quarter of 2025.
The increase came as food retail same-store sales rose 1.6%.
READ: Discount stores drive Loblaw's Q1 profit and sales, raises quarterly dividend
Drug retail same-store sales gained 4.6% as pharmacy and health-care services same-store sales gained 7.5% and front store same-store sales rose 1.3%.
On an adjusted basis, Loblaw says it earned 66 cents per diluted share in its latest quarter, up from an adjusted profit of 59 cents per diluted share in the second quarter of 2025.
RBC analyst Irene Nattel said in a note that Loblaw delivered another solid quarter.
She said food same-store sales and food revenue were in line with expectations, reflecting the ongoing discount-seeking consumer behaviour.
